Market Summary: The global market size for cell viability assays reached USD 3.26 Billion in 2020, with an anticipated Compound Annual Growth Rate (CAGR) of 8.7% throughout the forecast period. Key drivers fueling this growth include the increasing prevalence of chronic and infectious diseases, a growing emphasis on cell-based therapeutics, and augmented funding for cell-based research endeavors from both public and private sectors.
The surge in chronic ailments such as heart disease, obesity, diabetes, and cancer, attributed to sedentary lifestyles, rapid urbanization, unhealthy dietary habits, and a burgeoning geriatric population, is expected to drive the adoption of cell viability assays for research purposes. Moreover, advancements in stem cell research are poised to further bolster market growth over the forecast period.
Get a sample copy of the Cell Viability Assays Market report: https://www.reportsanddata.com/download-free-sample/4084
Cell viability assays play a critical role in evaluating the health and vitality of cells, optimizing experimental conditions, and assessing cell survival post-treatment with various compounds or reagents. They provide insights into cellular metabolic activity, ATP synthesis, proliferation, and toxicity, serving as indispensable tools in drug development, toxicity testing, and stem cell research.
While the demand for advanced healthcare infrastructure and medical facilities continues to rise, constraints such as the time-consuming nature of cell viability assays and the high costs associated with reagents and instruments may impede market growth to some extent.
Market Dynamics:
- Driver: The escalating global burden of chronic and infectious diseases has propelled the demand for cell-based assays, facilitating the development of prompt treatment and diagnostic solutions.
- Restraint: Challenges such as the scarcity of skilled professionals and the high costs of equipment hinder the widespread adoption of cell viability assay kits, particularly in smaller healthcare settings.
Product Overview: The global market for cell viability assays comprises consumables and instruments, with consumables expected to dominate the market share owing to increased consumption in various viability experiments. These consumables include reagents, assay kits, and microplates, with rising investments in R&D activities driving demand.
Application Scope: Cell viability assays find applications in basic research, stem cell research, drug discovery and development, clinical diagnostics, among others, with drug discovery and development projected to witness substantial revenue growth. The rise in chronic illnesses and infectious diseases underscores the need for efficient treatment modalities, thereby fueling demand in this segment.
End-Use Industry Analysis: Pharmaceutical and biotechnology companies are anticipated to exhibit robust revenue growth, driven by increased R&D activities, a focus on stem cell research, and the utilization of viability assays in drug development. These assays are crucial for evaluating the efficacy of anti-cancer therapeutics and diagnosing cancers accurately, further stimulating demand.
Regional Outlook: North America is poised to command a significant revenue share, attributed to factors such as the increasing burden of infectious diseases, substantial funding for stem cell research, and well-established healthcare infrastructure. Europe and Asia Pacific are also expected to witness considerable growth, fueled by rising research activities and healthcare budgets in these regions.
Competitive Landscape: The global cell viability assays market is fragmented, with major players such as Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, among others, focusing on product development and strategic alliances to cater to growing demand and solidify their market presence.
Key Developments: In April 2021, Halo Labs introduced Aura CL, a next-generation instrument line designed to revolutionize cell therapy product quality analysis, thereby addressing the evolving needs of the market.
Segments Covered in the Report: The report provides a comprehensive analysis of the cell viability assays market, segmenting it based on product, application, end-use industry, and region, with historical data and revenue forecasts offering insights into market trends and growth prospects.
Market Scope:
- Market Size (2020): USD 3.26 Billion
- CAGR (2020 - 2028): 8.7%
- Revenue Forecast (2028): USD 1,371 Million
- Geographic Scope: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
- Key Companies: Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Becton, Dickinson and Company, Merck KGaA, GE Healthcare, BioTek Instruments, PerkinElmer, Promega Corporation, Biotium, Abcam Plc., Canvax, Danaher Corporation, Creative Bioarray
Customization: The report offers 10 hours of free customization and expert consultation, enabling stakeholders to tailor insights to their specific requirements.
Explore Trending Reports:
Industrial Coatings Market-https://www.reportsanddata.com/report-detail/industrial-coatings-market
Trivalent Chromium Finishing Market-https://www.reportsanddata.com/report-detail/trivalent-chromium-finishing-market
Cosmetic Chemicals Market-https://www.reportsanddata.com/report-detail/cosmetic-chemicals-market
Coating Additives Market-https://www.reportsanddata.com/report-detail/coating-additives-market
Pigment Dispersion Market-https://www.reportsanddata.com/report-detail/pigment-dispersion-market
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/4084
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
English